期刊
JOURNAL OF INFECTIOUS DISEASES
卷 190, 期 2, 页码 335-340出版社
UNIV CHICAGO PRESS
DOI: 10.1086/421033
关键词
-
资金
- NCRR NIH HHS [K12 RR017697] Funding Source: Medline
- NIAID NIH HHS [N01 AI-25465, N01 AI-65316, N01 AI-25462] Funding Source: Medline
Background. Passively acquired maternal antibodies protect infants from many pathogens. With increasing reports of infant pertussis, we evaluated pertussis antibodies in maternal-infant paired sera from 1999 - 2000. Methods. Antibodies to pertussis toxin ( PT), filamentous hemagglutinin (FHA), and fimbrial proteins (FIM) were measured by validated IgG-specific enzyme-linked immunosorbant assay ( ELISA) in 64 maternal - umbilical cord serum pairs and in 61 of 64 infant sera. Geometric mean concentrations (GMCs) of pertussis antibodies and cord: maternal GMC ratios were calculated. Results. Mean maternal age and gestation were 29.7 years ( range, 19 - 42) and 39.3 weeks ( range, 35.6 - 40.9), and 81% of mothers were white. GMCs of maternal antibodies at delivery ( ELISA units/mL) were 2.4 for PT, 6.9 for FHA, and 13 for FIM. Cord GMCs were 169%, 178%, and 157% of maternal delivery values for PT, FHA, and FIM, respectively, demonstrating active placental transfer (P < .001). Pertussis-specific IgG values for each antigen decayed to below the threshold of detection by age 2 months. Conclusions. Despite efficient placental transfer, low maternal pertussis antibody levels and their rapid decay in infant sera leave infants with little humoral protection against pertussis. These data support the rationale for maternal or neonatal immunization, with acellular pertussis vaccines, to prevent life-threatening pertussis in early infancy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据